• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2000529 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2020-10-22 Lilly France Lilly France In Review 2020-10-21 view
JYSB2000528 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2020-10-22 Lilly France Lilly France In Review 2020-10-21 view
JYSB2000506 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2020-10-13 Lilly France Lilly France Certificate Issued 2020-11-26 view
JYSB2000505 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2020-10-13 Lilly France Lilly France Certificate Issued 2020-11-26 view
JYSB2000440 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2020-09-08 Lilly France Lilly France Filed 2020-09-18 view
JYSB2000439 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2020-09-08 Lilly France Lilly France Filed 2020-09-18 view
JYSB2000262 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2020-06-18 Lilly France Lilly France Filed 2020-06-22 view
JYSB2000261 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2020-06-18 Lilly France Lilly France Filed 2020-06-22 view
JYSB2000260 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2020-06-18 Lilly France Lilly France Filed 2020-06-22 view
JYSB2000263 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2020-06-18 Lilly France Lilly France Filed 2020-06-22 view
JYSB1900183 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2019-07-26 Lilly France Lilly France Certificate Issued 2019-11-01 view
JYSB1900180 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2019-07-26 Lilly France Lilly France Certificate Issued 2019-11-01 view
JYSB1900182 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2019-07-22 Lilly France Lilly France Certificate Issued 2019-11-01 view
JYSB1900181 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2019-07-22 Lilly France Lilly France Certificate Issued 2019-11-01 view
JYSB1900021 精蛋白锌重组人胰岛素注射液(预混30R) Injection Biological Products Supplementary Application 2019-01-23 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2020-02-17 view
JYSB1900012 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2019-01-23 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2020-02-17 view
JYSB1900020 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2019-01-23 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2020-03-03 view
JYSB1900010 精蛋白锌重组人胰岛素注射液 Protamine Zinc Recombinant Human Insulin Injection Biological Products Supplementary Application 2019-01-23 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2020-02-17 view
JYSB1900017 精蛋白锌重组人胰岛素注射液(预混30R) Injection Biological Products Supplementary Application 2019-01-23 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2020-02-17 view
JYSB1900009 精蛋白锌重组人胰岛素注射液(预混30R) Injection Biological Products Supplementary Application 2019-01-23 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2020-02-17 view